Related Experiment Videos

Effects of phototherapy on serum unbound bilirubin i icteric newborn infants

Biology of the Neonate
|January 1, 1981
PubMed

Insights

Phototherapy significantly reduces unbound bilirubin in infants with hyperbilirubinemia. This treatment effectively lowers both unbound and total bilirubin levels in preterm and full-term newborns.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Phototherapy Research

Background:

  • Hyperbilirubinemia is a common condition in newborns.
  • Unbound bilirubin is considered the toxic fraction responsible for kernicterus.
  • Phototherapy is a standard treatment for neonatal jaundice.

Purpose of the Study:

  • To evaluate the impact of phototherapy on serum unbound bilirubin levels.
  • To compare the reduction in unbound versus total bilirubin.
  • To assess phototherapy's efficacy in both preterm and full-term infants.

Main Methods:

  • Assayed serum samples from 39 preterm and 35 full-term infants.
  • Measured unbound bilirubin using the peroxidase oxidation method.
  • Monitored bilirubin levels at 24 and 48 hours during continuous phototherapy.

Main Results:

  • Statistically significant declines in serum unbound bilirubin were observed.
  • Both unbound/total bilirubin ratios and absolute levels decreased significantly.
  • Reductions were noted in both preterm and full-term infant groups.

Conclusions:

  • Phototherapy effectively reduces serum unbound bilirubin in infants.
  • The decline in unbound bilirubin is more pronounced than the decline in total bilirubin.
  • Phototherapy is a crucial intervention for managing hyperbilirubinemia in neonates.

Related Concept Videos